Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 08, 2024

SELL
$67.31 - $124.76 $10,971 - $20,335
-163 Reduced 5.06%
3,061 $295 Million
Q3 2023

Nov 14, 2023

BUY
$102.5 - $123.59 $122,487 - $147,690
1,195 Added 58.9%
3,224 $391 Million
Q2 2023

Aug 11, 2023

BUY
$106.4 - $157.19 $215,885 - $318,938
2,029 New
2,029 $232 Million
Q4 2022

Feb 14, 2023

BUY
$100.86 - $132.13 $343,125 - $449,506
3,402 New
3,402 $441 Million

Others Institutions Holding SRPT

About Sarepta Therapeutics, Inc.


  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $10.9B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track Inceptionr LLC Portfolio

Follow Inceptionr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Inceptionr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Inceptionr LLC with notifications on news.